학술논문

A phase I trial of amsalog (Cl-921) administered by intravenous infusion using a 5-day schedule
Document Type
Journal
Source
CANCER CHEMOTHERAPY AND PHARMACOLOGY; APR 2001, 47 4, p333-p337, 5p.
Subject
Language
English
ISSN
03445704